Gene · 64321
Papers4,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combination of melt-electrospun poly-ε-caprolactone scaffolds and hepatocyte-like cells from footprint-free hiPSCs to create 3D biohybrid constructs for liver tissue engineering. | Sci Rep | 2023 | 38092880 | PubTator, text mining | PubMed |
| CRISPR loss of function screening to identify genes involved in human primordial germ cell-like cell development. | PLoS Genet | 2023 | 38091369 | PubTator, text mining | PubMed |
| Efficient gene editing in induced pluripotent stem cells enabled by an inducible adenine base editor with tunable expression. | Sci Rep | 2023 | 38081875 | PubTator, text mining | PubMed |
| Leptomeningeal Neural Organoid (LMNO) Fusions as Models to Study Meninges-Brain Signaling. | bioRxiv | 2023 | 38077064 | PubTator, text mining | PubMed |
| Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients. | Int J Mol Sci | 2023 | 38069396 | PubTator, text mining | PubMed |
| Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis. | Int J Mol Sci | 2023 | 38068961 | PubTator, text mining | PubMed |
| Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review. | Cancers (Basel) | 2023 | 38067304 | PubTator, text mining | PubMed |
| Ultrastructural Abnormalities in Induced Pluripotent Stem Cell-Derived Neural Stem Cells and Neurons of Two Cohen Syndrome Patients. | Cells | 2023 | 38067130 | PubTator, text mining | PubMed |
| A Comparative Study of Endoderm Differentiation Between Activin A and Small Molecules. | Exp Clin Endocrinol Diabetes | 2023 | 38056491 | PubTator, text mining | PubMed |
| Urine-derived cells from the aged donor for the 2D/3D modeling of neural cells via iPSCs. | Aging Brain | 2023 | 38045491 | PubTator, text mining | PubMed |
| SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors. | Nat Commun | 2023 | 38040699 | PubTator, text mining | PubMed |
| EZH2 K63-polyubiquitination affecting migration in extranodal natural killer/T-cell lymphoma. | Clin Epigenetics | 2023 | 38031139 | PubTator, text mining | PubMed |
| Light at the ENDothelium-role of Sox17 and Runx1 in endothelial dysfunction and pulmonary arterial hypertension. | Front Cardiovasc Med | 2023 | 38028440 | PubTator, text mining | PubMed |
| Application and development of nanomaterials in the diagnosis and treatment of esophageal cancer. | Front Bioeng Biotechnol | 2023 | 38026877 | PubTator, text mining | PubMed |
| Human pluripotent stem cell fate trajectories toward lung and hepatocyte progenitors. | iScience | 2023 | 38026193 | PubTator, text mining | PubMed |
| Unveiling the novel immune and molecular signatures of ovarian cancer: insights and innovations from single-cell sequencing. | Front Immunol | 2023 | 38022625 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| The construction of a testis transcriptional cell atlas from embryo to adult reveals various somatic cells and their molecular roles. | J Transl Med | 2023 | 38012716 | PubTator, text mining | PubMed |
| Response by Walters et al to Letter Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension". | Circulation | 2023 | 38011243 | PubTator, text mining | PubMed |
| Letter by Li et al Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension". | Circulation | 2023 | 38011241 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64321/papers?page=16